What does lacosamide do to heart rhythm and pulse?
Lacosamide is known to affect cardiac electrical conduction, which can change heart rate and rhythm. Its main heart-related effects are linked to conduction slowing (for example, it can prolong PR interval) and can lead to rhythm disturbances in some people, such as bradycardia or, less commonly, other conduction-related arrhythmias. Those rhythm effects can show up as a change in pulse rate, depending on the individual and baseline rhythm status. [1][2]
How can lacosamide change both pulse rate and blood pressure at the same time?
When lacosamide slows cardiac conduction, the immediate pulse effect is often a slower heart rate (bradycardia). A slower heart rate can secondarily lower cardiac output in some settings, which can contribute to lower blood pressure. In practice, this means clinicians watch for combined findings such as:
- lower pulse rate with concurrent drop in BP, especially in people who already have conduction disease or are on other medications that slow the heart, and
- dizziness, faintness, or weakness that can occur if blood pressure falls.
The pattern is not guaranteed for every patient, but it’s the physiologic pathway clinicians look for: conduction slowing → bradycardia → possible hypotension. [1][2]
What increases the risk of pulse/BP drops on lacosamide?
Risk is higher when lacosamide is combined with other factors that affect conduction or blood pressure, such as:
- existing conduction abnormalities (for example, AV block)
- concomitant heart-rate–slowing drugs (such as certain beta blockers, non-dihydropyridine calcium channel blockers, or other antiarrhythmics)
- older age and underlying cardiac disease
- dosing changes or rapid titration in susceptible patients
These situations make bradycardia more likely, which increases the chance that BP may also fall. [1][2]
What should patients watch for (symptoms that suggest problematic pulse/BP changes)?
Patients should seek urgent care if they develop symptoms consistent with significant bradycardia or hypotension while taking lacosamide, such as:
- fainting or near-fainting
- severe dizziness or lightheadedness
- unusual fatigue or weakness that comes with slow pulse
- palpitations with feeling unwell
- chest discomfort
These can reflect clinically significant conduction effects or low blood pressure. [1][2]
How soon after starting or changing lacosamide can pulse and BP effects appear?
Cardiac conduction effects can occur soon after dose changes in susceptible people, so pulse and BP monitoring is often emphasized during initiation and titration, particularly for those with risk factors for conduction problems. [1][2]
What’s the practical clinical approach to monitoring pulse and BP together?
Clinicians typically:
- check baseline heart rhythm (ECG considerations) in higher-risk patients
- monitor pulse and BP after starting and during dose increases
- reassess if bradycardia, symptoms of hypotension, or ECG conduction worsening occurs
- adjust or discontinue if clinically significant rhythm/BP effects develop
This monitoring strategy is designed to catch the combined pulse+B P impact early. [1][2]
Sources
- https://www.accessdata.fda.gov/drugsatfda_docs/label/
- https://www.ema.europa.eu/